Figure 8.
Diagram showing the mechanism by which E2 negatively regulates TGF-βRI gene transcription. Under the condition of IRI, a decrease in the E2 level by OVX reduces the transcriptional inhibition of TGF-βRI, and activating TGF-βRI activates pSMAD2/3, thus promoting the release of proinflammatory factors. After supplementation, E2 enters the nucleus, binds to ERα, binds to the ERE of the TGF-βRI promoter, and represses its transcription.